The notion that c-Abl functions as a suppressor of mammary tumorigenesis is further supported by the findings presented in Figure 1A, which shows c-Abl transcripts to be significantly downregulated in ~70% of breast cancers. The gene discussed is ABL1; the disease is breast cancer.